focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Regulatory News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)

16 Dec 2019 11:55

RNS Number : 9687W
Arden Partners plc
16 December 2019
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Arden Partners plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Open Orphan plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Open Orphan plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13 December 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

284,960

0.11%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

284,960

0.11%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

0.1p ordinary

Sales

250,000

5.49p

5.49p

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

16 December 2019

Contact name:

Samantha Cook

Telephone number:

020 7614 5927

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEAPAKFSENFEF
Date   Source Headline
29th Jan 20204:43 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSCompulsory Acquisition of Remaining hVIVO Shares
27th Jan 20203:00 pmRNSHolding(s) in Company
23rd Jan 20207:00 amRNSUpdate on Placing
22nd Jan 20209:58 amRNSHolding(s) in Company
22nd Jan 20209:48 amRNSHolding(s) in Company
21st Jan 20202:07 pmRNSHolding(s) in Company
20th Jan 20204:28 pmRNSHolding(s) in Company
20th Jan 20208:00 amRNSEuronext Growth Dublin Notice
20th Jan 20207:59 amRNSEuronext Growth Dublin Cancellation Notice
20th Jan 20207:00 amRNSCompletion of Merger with hVIVO and Re-Admission
17th Jan 20207:00 amRNSOffer Wholly Unconditional
16th Jan 20202:00 pmRNSSchedule One Update
16th Jan 20202:00 pmRNSSchedule One Update - Open Orphan PLC
15th Jan 20205:30 pmRNSOpen Orphan
14th Jan 202011:12 amGNWForm 8.3 - Open Orphan plc
14th Jan 20207:00 amRNSSecond Closing of the Offer
13th Jan 20209:00 amRNSPrice Monitoring Extension
7th Jan 20202:12 pmRNSPublication and Posting of Rule 15 Proposals
6th Jan 20201:17 pmRNSResult of General Meeting
6th Jan 20208:00 amRNSSchedule One - Open Orphan plc
6th Jan 20208:00 amRNSSchedule One
6th Jan 20207:00 amRNSNew 3 Year Contract
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
2nd Jan 202011:44 amRNSForm 8.3 - Open Orphan PLC
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 20197:00 amRNSOffer Update
30th Dec 201910:00 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 201910:00 amRNSForm 8.5 (EPT/RI) - Open Orphan plc
23rd Dec 20199:30 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20195:39 pmRNSForm 8.3 - Open Orphan Plc
19th Dec 20194:39 pmRNSForm 8.3 - Open Orphan plc
19th Dec 20191:36 pmRNSForm 8.3 - Open Orphan plc
19th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
18th Dec 201912:05 pmRNSForm 8.5 (EPT/NON-RI)
18th Dec 20197:00 amRNSNew Contract with SFA Therapeutics
17th Dec 20194:38 pmRNSForm 8.3 - Open Orphan Plc
17th Dec 20194:36 pmRNSForm 8 (OPD)
17th Dec 20192:06 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:06 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:04 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:04 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
17th Dec 201910:19 amRNSForm 8 (OPD)
17th Dec 201910:19 amRNSForm 8 (OPD) (hVIVO plc)
16th Dec 20192:02 pmRNSForm 8 (OPD) Open Orphan plc
16th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201910:26 amRNSForm 8.5 (EPT/RI) - Open Orphan plc
13th Dec 201911:44 amRNSForm 8.3 - Open Orphan PLC
13th Dec 20197:00 amRNSForm 8.3 - Open Orphan plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.